Beta-Alanine
CAS 107-95-9
Beta-Alanine (CAS 107-95-9) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 41463.55111111111 nM | 9 | - |
| - | Potency | 7791.4 nM | 2 | - |
| - | EC50 | 20 % | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| Glycine Receptor (All subtypes) | Partial agonist | 4.3 pEC50 | 9009272 |
| MRGPRD Mrgprd |
Agonist | 4.85 pEC50 | 15037633 |
| MRGPRD Mrgprd |
Agonist | 4.36 pEC50 | 15037633 |
| MRGPRD MRGPRD |
Full agonist | 4.8 pEC50 | 15037633|23396314 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| .BETA.-ALANINE | 61 | SU | MTHSPL |
| beta-alanine | 61 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Beta-Alanine used for in pharmaceutical contexts?
Beta-Alanine (CAS 107-95-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Beta-Alanine?
No adverse-event association or SIDER side-effect rows are rendered for Beta-Alanine in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Beta-Alanine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Beta-Alanine with EU status "permitted".
What clinical phase is Beta-Alanine in?
No phase 1-4 clinical development badge is rendered for Beta-Alanine because the matched compound identifier rows do not contain a max-phase value.